Posted by Admin | 1:32 PM

On the heels of our discussion of how one pharmaceutical company employed a "publications strategy" to commission and control ran...

Labels: BMP-2, conflicts of interest, deception, ghost writing, manipulating clinical research, Medtronic

Posted by Admin | 9:58 AM

Here are a few reasonable questions I decided to elevate as a post of its own. In the face of the discovery of industry influence over comme...

Labels: ghost writing, ghostwriting, meaningful use final rule, meaningful use stage 2, ONC, regulatory capture, stealth lobbying

Posted by Admin | 6:22 AM

Note: Also see the followup Sept. 5, 2012 post " Was EPIC successful in watering down the Meaningful Use Stage 2 Final Rule? " at ...

Labels: conflicts of interest, Dayton Children's Hospital, EPIC, ghost writing, ghostwriting, meaningful use stage 2, ONC, stealth lobbying, University of Miami